BRCA1/2 mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling

OBJECTIVE: The characteristics of patients with metachronous breast and ovarian malignancies and the pathogenic role of BRCA1/2 mutations remain poorly understood. We investigated these issues through a review of hospital records and nationwide Taiwanese registry data, followed by BRCA1/2 mutation a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Angel, Lin, Yi-Hao, Yang, Lan-Yan, Wu, Ren-Chin, Chang, Wei-Yang, Chang, Pi-Yueh, Chang, Shih-Cheng, Lin, Chiao-Yun, Huang, Huei-Jean, Lin, Cheng-Tao, Chou, Hung-Hsueh, Huang, Kuan-Gen, Kuo, Wen-Ling, Chang, Ting-Chang, Lai, Chyong-Huey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189074/
https://www.ncbi.nlm.nih.gov/pubmed/31912679
http://dx.doi.org/10.3802/jgo.2020.31.e24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189074/
https://www.ncbi.nlm.nih.gov/pubmed/31912679
http://dx.doi.org/10.3802/jgo.2020.31.e24

Ejemplares similares